coronavirus vaccine

Expert Panel Recommends Emergency-Use Okay for Covaxin in 2-18 Age Group

Why the Private Sector Hasn’t Been Able to Fulfil Its 25% COVID Vaccine Quota

What Links the Covaxin Scandal in Brazil and Kumbh Fake-Tests Scam in India?

COVID-19 Vaccines for Children Will Be Launched ‘Very Soon’: Mandaviya

‘Impossible to Fully Vaccinate All Adults in 2021, Govt Mistakes to Blame’

Bharat Biotech Releases Long-Awaited Covaxin Phase 3 Data, Claims 77.8% Efficacy

India Refuses Emergency Use License for One-Dose Sputnik